Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RAPS Taiwan Chapter Leads Way For Further Asian Expansion

This article was originally published in PharmAsia News

Executive Summary

The Regulatory Affairs Professionals Society has chosen the island ahead of other candidates to form its first chapter in Asia, as it expands its footprint in the region and around the world.

You may also be interested in...



Regulatory Affairs Professionals Society Teams Up With Shanghai University To Design Continents-spanning Courses In Healthcare

BEIJING - The U.S.-headquartered Regulatory Affairs Professionals Society is teaming up in a unique partnership with the University of Shanghai for Science and Technology to design special course curricula and content on healthcare regulation, according to the society's leadership

Strong Innovent IPO Restoring Faith In HK Biotech Listings?

Suzhou-based Innovent Bio becomes the fourth biotech from mainland China to go public in Hong Kong, and its strong first-day performance may have given the seemingly spooked market so far for such companies a shot of confidence.

China Biotech Innovation Reaching Tipping Point?

A rapidly reforming policy and regulatory environment and a growing culture of innovation are encouraging capital and talent to pour into China, making it a question of when, rather than if, the payoffs will come for both consumers and investors.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC086903

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel